Skip to content

Downloads

Date Title Documents

Amarin Q1 2018 Earnings Presentation

2018 Proxy Statement

2017 AMCO Statutory Accounts

April Investor Presentation

Amarin Q4 2017 Earnings Presentation

March Investor Presentation

January Investor Presentation

CA Declaration of Compliance 2017

AMARIN SPONSORS MULTIPLE SCIENTIFIC STUDY PRESENTATIONS SCHEDULED FOR 2017 AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS

Amarin Q3 2017 Earnings Presentation

copyright
© 2018, Amarin Corporation
Privacy policy  |  Disclaimer
Dublin Office
2 Pembroke House, Upper Pembroke
Street 28-32
Dublin 2, Ireland
US Investor Relations
Amarin Pharma Inc.
1430 Route 206
Bedminster, NJ 07921 USA
Telephone:
+1 908 719 1315
Fax:
+1 908 719 3012

Amarin Corporation